1.0GenoScreenhttps://www.genoscreen.fr/en/rich600338<blockquote class="wp-embedded-content" data-secret="DcotLp4bcm"><a href="https://www.genoscreen.fr/en/regulatory-services/feed-additives-enzymes/">Feed Additives & Enzymes</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.genoscreen.fr/en/regulatory-services/feed-additives-enzymes/embed/#?secret=DcotLp4bcm" width="600" height="338" title="“Feed Additives & Enzymes” — GenoScreen" data-secret="DcotLp4bcm" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.genoscreen.fr/wp-includes/js/wp-embed.min.js </script> https://www.genoscreen.fr/wp-content/uploads/Banniere_Feed.png1141210In 2023, 40% of new applications for food additives involving microorganisms were rejected by EFSA due to issues with strain characterization, often resulting in significant losses of time and money. Partnering with an experienced company like GenoScreen can minimize preventable errors and increase approval success rates.